Combination chemotherapy for hepatitis B virus: The final solution?

被引:29
作者
Shaw, T [1 ]
Locarnini, S [1 ]
机构
[1] Victorian Infect Dis Reference Lab, N Melbourne, Vic, Australia
关键词
D O I
10.1053/jhep.2000.16181
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:430 / 432
页数:3
相关论文
共 37 条
  • [1] Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
    Allen, MI
    Deslauriers, M
    Andrews, CW
    Tipples, GA
    Walters, KA
    Tyrrell, DLJ
    Brown, N
    Condreay, LD
    [J]. HEPATOLOGY, 1998, 27 (06) : 1670 - 1677
  • [2] Balzarini J, 1999, BIOCHEM PHARMACOL, V58, P1
  • [3] Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
    Chayama, K
    Suzuki, Y
    Kobayashi, M
    Kobayashi, M
    Tsubota, A
    Hashimoto, M
    Miyano, Y
    Koike, H
    Kobayashi, M
    Koida, I
    Arase, Y
    Saitoh, S
    Murashima, N
    Ikeda, K
    Kumada, H
    [J]. HEPATOLOGY, 1998, 27 (06) : 1711 - 1716
  • [4] Update on highly active antiretroviral therapy: progress and strategies
    Clumeck, N
    De Wit, S
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (01) : 7 - 12
  • [5] Colacino JM, 1998, PROG DRUG RES, V50, P259
  • [6] A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance
    Colgrove, R
    Japour, A
    [J]. ANTIVIRAL RESEARCH, 1999, 41 (01) : 45 - 56
  • [7] In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir
    Colledge, D
    Civitico, G
    Locarnini, S
    Shaw, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 551 - 560
  • [8] Colledge D, 1997, HEPATOLOGY, V26, P216
  • [9] Perspectives for the treatment of hepatitis B virus infections
    De Clercq, E
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 (02) : 81 - 95
  • [10] A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B
    de Man, RA
    Marcellin, P
    Habal, F
    Desmond, P
    Wright, T
    Rose, T
    Jurewicz, R
    Young, C
    [J]. HEPATOLOGY, 2000, 32 (02) : 413 - 417